European Pharmaceutical Market Access, Pricing & Reimbursement 2016 Conference

October 10-11, 2016 - London, United Kingdom

Conference Proceedings

Standard Price

US$ 623.75

User Details



Our 22nd annual European Pharmaceutical Market Access, Pricing and Reimbursement conference returns to London from 10-11 October 2016. The conference is one of the most established in the world, focusing on the changes in pricing and reimbursement and market access.

As pharmaceutical global spending is predicted to increase by 29-32% by 2020, the need for access to cheaper alternative medicines and technology is essential. The use of generics is on the rise and it's expected that by 2020, 88% of total medicine use will be attributed to generics, over the counter, and non-original branded products.


This year's agenda will have a strong focus on the future of pricing and reimbursement. Other key topics include:

  • Updates on AMNOG and its implication on pricing and reimbursement
  • How biosimilars are affecting your pricing strategy
  • Capture on emerging markets' regulatory framework to adapt your market access and P&R models
  • Orphan drugs using recent examples to highlight the impact on pricing
  • Cancer drug funding and budget cuts in the UK
  • Innovative solutions beyond the pill
  • Japanese and Turkish regional updates


Benefits of Attending

Attend this conference to:
  • Learn about new strategies, their strengths, weaknesses and future implications
  • Gain an insight into new pricing strategies in oncology
  • Hear about regional updates and understand how we can learn from these
  • Recognise current trends in HTA: Harmonization of HTA
  • Understand how to use pricing data to maximize profit
  • Consider how biosimilars affect pricing and reimbursement


Plus Two Interactive Half-Day Post-Conference Workshops | Wednesday 12th October 2016

A: HTA and reimbursement decisions for innovative medicines
08.30 - 12.30
Workshop Leader: Patrick Mollon, Former Director of Health Economic & Outcomes Research, Novartis; HEOR Director, PMHE2020

B: Managing the global to local challenge
13.30 - 17.30
Workshop Leader: Janice Haigh, Practice Leader, Quintiles

Speakers

  • Alexander Natz, Director, EUCOPE
  • Bertram Haussler, Chairman of the Board of Management, IGES Institut
  • David Watson, Director of Pricing and PPRS, Association of the British Pharmaceutical Industry (ABPI)
  • Donald Macarthur, Adviser, Proceutica
  • Gordon Spencer, Regional Market Access Lead, EU & Canada , Shire
  • Jorge Mestre-Ferrandiz, Director of Consulting, Office of Health Economics
  • Ken Walsh, Senior Principal, Payer Strategy , Evidera
  • Panos Kafalas, Head of Health Economics and Market Access, Cell and Gene Therapy Catapult
  • Patrick Mollon, Former Director Global Health Economics and Outcomes Research; HEOR Director, Novartis; PMHE2020
  • Rasmus Jensen, Owner; Former Director and Head of Market Access, Drewes Jensen Consult; Lundbeck
  • Simone Breitkopf, Head HEOR, Governmental and Public Affairs, Alcon
  • Smita Sealey, UK Engagement Manager, Market Access, IMS Health
  • Ulf Staginnus, Head Market Access Oncology Region Europe, Baxalta

Please fill in your name and email to receive the conference agenda of this event.


The agenda is available as PDF under dwonloads at the right side of the page.

Venue

Holiday Inn Kensington Forum
97 Cromwell Rd, Kensington, SW7 4DN
London, UK

Who should attend

CEO, Directors, Associate Directors, Senior Managers, Managers, Presidents, Vice-Presidents, Senior Consultants, Consultants, Professors in the following fields:
  • Pricing
  • Market Access
  • Health Economics
  • Regulatory
  • HEOR
  • Business Development
  • Marketing
  • Commercial Pricing
  • Medical Affairs
  • Government Affairs
  • Strategic Development


Venue

Holiday Inn Kensington Forum
97 Cromwell Road
London, United Kingdom
Event details
Organizer :SAE Media Group
Event type :Conference
Attendance :Physical Event
Reference :ASDE-15396